Lack of changes in beta-endorphin plasma levels after repeated treatment with fluoxetine: Possible implications for the treatment of alcoholism - A pilot study

Pharmazie

Volumn 63, Issue 4, 2008, Pages 308-311

  Zalewska Kaszubska, Jadwiga ^a   Gorska D ^a   Dyr, W ^b   Czarnecka, E ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BETA ENDORPHIN; FLUOXETINE; SODIUM CHLORIDE;

ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; LONG TERM EXPOSURE; NONHUMAN; PILOT STUDY; PROTEIN BLOOD LEVEL; RAT;

ALCOHOLISM; ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BETA-ENDORPHIN; FEMALE; FLUOXETINE; HALF-LIFE; PILOT PROJECTS; RATS; SPECIES SPECIFICITY;

EID: 42149173151     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.7750     Document Type: Article

References (46)

1. Angwin P, Barchas JD (1982) Use of silicic acid extraction and reversed-phase columns for rapid purification prior to radioimmunoassay. J Chromatogr 231: 173-177.
2. Balldin J, Berggren U, Engel J, Eriksson M (1994) Neuroendocrine evidence for reduced serotonergic neurotransmission during heavy drinking. Alcohol Clin Exp Res 18: 822-825.
3. Berggren U, Eriksson M, Fahike C, Balldin J (2002) Is long-term heavy alcohol consumption toxic for brain serotonergic neurons? Relationship between years of excessive alcohol consumption and serotonergic neurotransmission. Drug Alcohol Depend 65: 159-165.
4. Borg S, Kvande H, Liljeberg P, Mossberg D, Valverius P (1985) 5-Hydroxyindoleacetic acid in cerebrospinal fluid in alcoholic patients under different clinical conditions. Alcohol 2: 415-418.
5. Bruni JF, Hawkins RL, Yen SS (1982) Serotonergic mechanism in the control of beta-endorphin and ACTH release in male rats. Life Sci 30: 1247-1254.
6. Caccia S, Cappi M, Fracasso C, Garattini S (1990) Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat. Psychopharmacology 100: 509-514.
7. Carr JA, Saland LC, Samora A, Benavidez S, Krobert K (1991) In vivo effects of serotonergic agents on alpha-melanocyte-stimulating hormone secretion. Neuroendocrinology 54: 616-622.
8. Ciccocioppo R (1999) The role of serotonin in craving: from basic research to human studies. Alcohol 34: 244-253.
9. Ciccocioppo R, Ge J, Barnes NM, Cooper SJ (1998) Central 5-HT3 receptors in P and AA alcohol preferring rats: An autoradiographic study. 46: 311-315.
10. Ciccocioppo R, Ge J, Barnes NM, Cooper SJ (1997) Autoradiographic mapping of brain 5-HT2A binding sites in P and AA alcohol-preferring rats. Brain Res Bull 44: 33-37.
11. Devoto P, Colombo G, Stefanini E, Gessa GL (1998) Alcohol Alcohol. Serotonin is reduced in the frontal cortex of Sardinian ethanol-preferring rats. 33: 226-229.
12. Dyr W, Kostowski W (2004) Preliminary phenotypic characterization of Warsaw high preferring (WHP) and Warsaw low preferring (WLP) lines of rats selectively bred for high and low ethanol consumption. Pol J Pharmacol 56: 359-365.
13. Gianoulakis C, Beliveau D, Angelogianni P, Meaney M, Thavundayil J, Tawar V, Dumas M (1989) Different pituitary beta-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholism. Life Sci 45: 1097-1109.
14. Gorelick DA, Paredes A (1992) Effect of fluoxetine on alcohol consumption in male alcoholics. Alcohol Clin Exp Res 16: 261-265.
15. Heinz A, Mann K, Weinberger DR, Goldman D (2001) Serotonergic dysfunction, negative mood states, and response to alcohol. Alcohol Clin Exp Res 25: 487-495.
16. Heinz A, Ragan P, Jones DW, Hommer D, Williams W, Knable MB, Gorey JG, Doty L, Geyer C, Lee KS, Coppola R, Weinberger DR, Linnoila M (1998) Reduced central serotonin transporters in alcoholism. Am J Psychiatry 155: 1544-1549.
17. Javors MA, Seneviratne C, Roache JD, Ait-Daoud N, Bergeson SE, Walss-Bass MC, Akhtar FZ, Johnson BA (2005) Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics Prog Neuropsychopharmacol Biol Psychiatry 29: 7-13.
18. Jones BC, Whitfield KE (1995) Sex differences in ethanol-related behaviors in genetically defined murine stocks. Recent Dev Alcohol 12: 223-230.
19. Johnson BA, Roache JD, Ait-Daoud N, Zanca NA, Velazquez M (2002) Ondansetron reduces the craving of biologically predisposed alcoholics. Psychopharmacology (Berl) 160: 408-413.
20. Kiefer F, Wiedemann K (2004) Neuroendocrine pathways of addictive behaviour. Addict Biol 9: 205-212.
21. Kranzler HR, Burleson JA, Korner P, Del Boca FK, Bohn MJ, Brown J, Liebowitz N (1995) Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Am J Psychiatry 152: 391-397.
22. LeMarquand D, Pihl RO, Benkelfat C (1994) Serotonin and alcohol intake, abuse and dependence: finding of animal studies. Biol Psychiatry 15: 395-421.
23. Lovinger D (1997) Serotonin's role in alcohol's effects on the brain. Alcohol Health Res Wordl 21: 114-120.
24. Martijena ID, Bustos SG, Bertotto ME, Molina VA (2005) Antidepressants attenuate both the enhanced ethanol intake and ethanol-induced anxiolytic effects in diazepam withdrawn rats. Eur Neuropsychopharmacol 15: 119-130.
25. McBride WJ, Chernet E, Rabold JA, Lumeng L, Li TK (1993) Serotonin-2 receptors in the CNS of alcohol-preferring and -nonpreferring rats. Pharmacol Biochem Behav 46: 631-636.
26. Murphy JM, Waller MB, Gatto GJ, McBride WJ, Lumeng L, Li TK (1988) Effects of fluoxetine on the intragastric self-administration of ethanol in the alcohol preferring P line of rats. Alcohol 5: 283-286.
27. Naranjo CA, Poulos CX, Bremner KE, Lanctot KL (1994) Fluoxetine attenuates alcohol intake and desire to drink. Int Clin Psychopharmacol 9: 163-72.
28. Olive MF, Koenig HN, Nannini MA, Hodge CW (2001) Stimulation of endorphin neurotransmission in the nucleus accumbens by ethanol, cocaine and amphetamine. J Neurosci 21: RC184
29. Patkar AA, Gopalakrishnan R, Naik PC, Murray HW, Vergare MJ, Marsden CA (2003) Changes in plasma noradrenaline and serotonin levels and craving during alcohol withdrawal. Alcohol Alcohol 38: 224-231.
30. Petraglia F, Facchineti F, Martignoni E, Nappi G, Volpe A, Genazzani AR (1984) Serotoninergic agonists increase plasma levels of beta-endorphin and beta-lipotropin in humans. J Clin Endocrinol Metab 59: 1138-1142.
31. Roberts AJ, Smith AD, Weiss F, Rivier C, Koob GF (1998) Estrous cycle effects on operant responding for ethanol in female rats. Alcohol. Clin Exp Res 22: 1564-1569.
32. Sacerdote P, Brini A, Mantegazza P, Panerai AE (1987) A role for serotonin and beta-endorphin in the analgesia induced by some tricyclic anti-depressant drugs. Pharmacol Biochem Behav 26: 153-158.
33. Sapun DI, Farah JM Jr, Mueller G (1981) Evidence that a serotonergic mechanism stimulates the secretion of pituitary beta-endorphin-like immunoreactivity in the rat. Endocrinology 109: 421-426.
34. Strother WN, Lumeng L, Li TK, McBride WJ (2005) Dopamine and serotonin content in select brain regions of weanling and adult alcohol drinking rat lines. Pharmacol Biochem Behav 80: 229-237.
35. Uzbay T, Saglam E, Kayir H, Celik T, Beyazyurek M (2004) Effects of fluoxetine on ethanol withdrawal syndrome in rats. J Psychiatr Res 38: 445-450.
36. Van Haaren F, Anderson K (1994) Sex differences in schedule-induced alcohol consumption. Alcohol 11: 35-40.
37. Van Ree JM (1996) Endorphins and experimental addiction. Alcohol 13: 25-30.
38. Van Ree JM, Kornet M, Goosen C (1994) Neuropeptides and alcohol addiction in monkeys. EXS 71: 165-174.
39. Walsch SL, Cunningham KA (1997) Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine. Psychopharmacology 130: 41-58.
40. Wiren KM, Hashimoto JG, Alele PE, Devaud LL, Price KL, Middaugh LD, Grant KA, Finn DA (2006) Impact of sex: determination of alcohol neuroadaptation and reinforcement. Alcohol Clin Exp Res 30: 233-242.
41. Zalewska-Kaszubska J, Cwiek W, Dyr W, Czarnecka E (2005) Changes in the beta endorphin plasma level after repeated treatment with acamprosate in rats selectively bred for high and low alcohol preference. Neurosci Lett 388: 45-48.
42. Zalewska-Kaszubska J, Czarnecka E (2005) Deficit in beta-endorphin peptide and tendency to alcohol abuse. Peptides 26: 701-705.
43. Zalewska-Kaszubska J, Gorska D, Dyr W, Czarnecka E (2006) Effect of acute administration of ethanol on beta-endorphin plasma level in ethanol preferring and non-preferring rats chronically treated with naltrexone. Pharmacol Biochem Behav 85: 155-159.
44. Zalewska-Kaszubska J, Obzejta D (2004) Use of low-energy laser as adjunct treatment of alcohol addiction. Lasers Med Sci 19: 100-104.
45. Zangen A, Nakash R, Yadid G (1999) Serotonin-mediated increases in the extracellular levels of β-endorphin in the arcuate nucleus and nucleus accumbens: a microdialysis study. J Neurochem 73: 2569-2574.
46. Zhou FC, Bledsoe S, Lumeng L, Li TK (1994) Reduced serotonergic immunoreactive fibers in the forebrain of alcohol-preferring rats. Alcohol Clin Exp Res 18: 571-579.